Radiation

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer

Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Vaccination With Flt3L, Radiation, and Poly-ICLC

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy